PAX6 rs121908871: Understanding This Rare Genetic Variant
The rs121908871 variant is a rare, pathogenic nonsense mutation located within the PAX6 gene. It is associated with congenital aniridia, a condition characterized by the partial or complete absence of the iris and other ocular developmental issues.
What each genotype means
Typical PAX6 function
This genotype represents the common, non-variant sequence for this location in the PAX6 gene. Individuals with this genotype do not carry the specific pathogenic nonsense mutation associated with congenital aniridia at this site.
This is the most common genotype found in the general population.
Increased risk of aniridia
This genotype indicates the presence of a heterozygous nonsense mutation in the PAX6 gene, which is associated with haploinsufficiency and the clinical presentation of congenital aniridia. Because PAX6-related ocular phenotypes are highly variable, individuals with this genotype may experience a range of symptoms including iris hypoplasia, foveal hypoplasia, or other anterior segment dysgenesis. Please consult with a clinical geneticist or ophthalmologist to discuss these findings in the context of your personal and family health history.
This specific genotype is extremely rare globally.
High risk of severe ocular development
This genotype indicates a homozygous state for the pathogenic nonsense variant, which is expected to result in a severe disruption of PAX6 protein function. Such variants are typically associated with significant congenital ocular malformations, including the absence of the iris and associated developmental eye disorders. Please consult with a clinical geneticist or ophthalmologist to discuss these findings in the context of your personal and family health history.
This genotype is exceptionally rare and has not been widely documented in population databases.
What is the rs121908871 Variant?
The rs121908871 variant is a specific genetic alteration found in the PAX6 gene, which is located on chromosome 11. In genetics, a nonsense variant like this one introduces a premature stop signal in the DNA sequence. This signal instructs the cell to stop building the PAX6 protein before it is complete, resulting in a truncated, nonfunctional protein. Because the body requires functional PAX6 protein for normal development, the presence of this variant can disrupt critical biological processes. This specific variant is categorized as a loss-of-function mutation, meaning it prevents the gene from performing its intended role in the body. It is considered a rare genetic event, and its presence is typically identified through clinical genetic testing when individuals present with specific ocular symptoms.
The Role of the PAX6 Gene
The PAX6 gene is a highly conserved master regulator that acts as a transcription factor, meaning it controls the activity of many other genes. It is essential for the proper formation of various tissues and organs before birth, most notably the eyes. PAX6 is expressed early in development in the eye, brain, and other neural tissues. By regulating the timing and expression of other genes, PAX6 ensures that the structures of the eye—including the iris, cornea, lens, and retina—develop correctly. When one copy of the PAX6 gene is nonfunctional, a state known as haploinsufficiency occurs. This means the body does not have enough of the PAX6 protein to support normal development, which is the primary mechanism behind conditions like congenital aniridia.
Research and Clinical Associations
Scientific research has firmly established that loss-of-function variants in PAX6 are the leading cause of congenital aniridia. Aniridia is a complex, pan-ocular disorder that often involves more than just the absence of the iris; it can also include corneal issues, cataracts, glaucoma, and foveal hypoplasia. While the evidence linking PAX6 loss-of-function variants to aniridia is strong, the specific clinical presentation can vary significantly between individuals, even those within the same family. Researchers continue to study how these variants lead to such a wide range of ocular symptoms. It is important to note that while this variant is associated with these conditions, genetic testing results should always be interpreted by a qualified medical geneticist or clinician who can provide context based on an individual's specific health history.
Population Frequency and Prevalence
The rs121908871 variant is classified as extremely rare in the general global population. Because it is a pathogenic variant associated with a significant developmental condition, it is not commonly found in large-scale population databases like gnomAD at high frequencies. Most individuals who carry this variant are identified through clinical diagnostic settings rather than population-wide screening. Because the condition is inherited in an autosomal dominant manner, an affected individual typically has a 50% chance of passing the variant to their offspring. However, many cases also arise as de novo mutations, meaning they occur spontaneously in an individual for the first time and are not inherited from either parent. Due to its rarity, there is limited data on its distribution across different ancestral groups.
What You Can Do With This Information
If you or a family member have been identified as a carrier of the rs121908871 variant, the most important step is to consult with a healthcare professional, such as a genetic counselor or an ophthalmologist specializing in genetic eye diseases. They can help explain what this result means for your health and the health of your family members. This information is primarily used for clinical diagnosis and family planning. It is not a tool for self-diagnosis or for predicting the exact severity of symptoms, as clinical outcomes can be influenced by many factors. Always discuss any concerns about vision or genetic risks with a qualified clinician who can provide personalized medical guidance and support based on your specific clinical presentation.
How common is this variant?
The rs121908871 variant is extremely rare globally, with no significant frequency observed in general population databases.
Frequently asked questions
What is PAX6 aniridia syndrome?
PAX6 aniridia syndrome is a genetic disorder characterized by the underdevelopment or absence of the iris. It often involves other eye complications like cataracts, glaucoma, and vision impairment.
Is aniridia always inherited?
No, aniridia can be inherited from a parent in an autosomal dominant pattern, but about one-third of cases are caused by a de novo mutation that occurs spontaneously.
Can a genetic test diagnose aniridia?
Genetic testing can identify pathogenic variants in the PAX6 gene, which helps confirm a clinical diagnosis of PAX6-related aniridia. However, diagnosis is usually based on a combination of clinical eye exams and genetic findings.
What should I do if I have a PAX6 variant?
You should schedule an appointment with a genetic counselor or an ophthalmologist. They can provide a clinical evaluation and discuss the implications for your health and family planning.
Sources & further reading
Educational information only, last refreshed 10/10/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121908871?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in PAX6
A high-penetrance single nucleotide substitution disrupting PAX6 function and leading to aniridia and congenital anterior segment dysgenesis.
Nonsense change in PAX6 leading to haploinsufficiency and classical congenital aniridia.
A classic nonsense mutation (p.Arg240Ter) in the PAX6 master regulator of eye development leading to haploinsufficiency and congenital aniridia.
Intronic regulatory polymorphism in the ocular master regulator PAX6 associated with axial length variation and myopia development.
Classical stop-gain variant in PAX6 leading to haploinsufficiency and congenital aniridia with associated foveal hypoplasia and decreased visual acuity.
Pathogenic missense variant in PAX6 causing developmental ocular malformations including aniridia and congenital ocular coloboma.